Cardiomyopathy laboratory findings: Difference between revisions
Lina Yaqoub (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
==Overview== | |||
* Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure. | Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure. Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome. Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients. | ||
* Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome. | ==Cardiomyopathy Laboratory Findings== | ||
* Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure.<ref name="pmid24976920">{{cite journal |vauthors=Sisakian H |title=Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies |journal=World J Cardiol |volume=6 |issue=6 |pages=478–94 |date=June 2014 |pmid=24976920 |doi=10.4330/wjc.v6.i6.478 |url=}}</ref> | |||
* Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome.<ref name="pmid24976920">{{cite journal |vauthors=Sisakian H |title=Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies |journal=World J Cardiol |volume=6 |issue=6 |pages=478–94 |date=June 2014 |pmid=24976920 |doi=10.4330/wjc.v6.i6.478 |url=}}</ref> | |||
* Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients. | * Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients. | ||
* Elevated troponin levels indicate ischemic heart disease, and should be investigated as much, till coronary arterial disease is ruled out. | * Elevated troponin levels indicate ischemic heart disease, and should be investigated as much, till coronary arterial disease is ruled out. | ||
| Line 11: | Line 13: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Genetic Disease]] | [[Category:Genetic Disease]] | ||
Revision as of 16:02, 31 December 2018
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy laboratory findings |
|
Risk calculators and risk factors for Cardiomyopathy laboratory findings |
Overview
Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure. Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome. Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients.
Cardiomyopathy Laboratory Findings
- Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure.[1]
- Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome.[1]
- Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients.
- Elevated troponin levels indicate ischemic heart disease, and should be investigated as much, till coronary arterial disease is ruled out.
- Elevated iron saturation and ferritin are indicative of hemochromatosis as a cause of cardiomyopathy.
References
Template:WH Template:WS Template:Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014;6(6):478-94